RECURSION PHARMACEUTICALS, INC.

RXRX · XNAS

CIK 1601830fmd_1P9BMY6J0J6GD4E7ZYCBVRS2ESManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods